Apricus Biosciences Inc.

(APRI) Trade

By |

Profile

Apricus Biosciences Inc is engaged in the pharmaceutical industry. The company develops and commercializes products and product candidates in the areas of urology and rheumatology. Apricus' drug delivery technology is a permeation enhancer called NexACT. The company has over two product candidates in Phase II development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa for the treatment of Raynaud's phenomenon.

Contact Information

Website: www.apricusbio.com
Email: ecox@apricusbio.com
Main Phone: +1 858 222-8041
Address: 11975 El Camino Real
Address 2: Suite 300
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Richard W. Pascoe
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.29 $ 0.012713 (4.61%)
Last Price 0.29 Change $ 0.012713 Change % 4.61 Tick N/A
Bid 0.28 Bid Size 100.00 Ask 0.28 Ask Size 200.00
Open 0.27 High 0.29 Low 0.27 Prev Close 0.28
Last Trade Volume 141,896 52 Wk Hi 3.34 52 Wk Low 0.25
Market Cap 8.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 28,167,329.00 EPS (TTM) -0.60 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 10
Number of Buys 1 3
Number of Sells 1 7
Net Activity 0 -53395
Last 10 Buys Shares
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Alexander J. Denner, 1,000
Brian T. Dorsey 1,000
Sandford Drexel Smith 1,000
Richard W. Pascoe 1,000
Sandford Drexel Smith 1,000
Last 10 Sell Shares
Leonard A. Oppenheim 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Kleanthis G. Xanthopoulos 1,000
Leonard A. Oppenheim 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4.3 4.3 4.3 4.3
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 2.65 2.65 2.65 2.65
Standard Deviation 2.33 2.33 2.33 2.33
Date of Most Recent Estimate 02/16/18 02/16/18 02/16/18 02/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3